Milrinone Lactate

TargetMol
Product Code: TAR-T1096L
Supplier: TargetMol
CodeSizePrice
TAR-T1096L-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1096L-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1096L-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Milrinone Lactate is a positive inotropic cardiotonic compound. Milrinone Lactate has vasodilator properties, inhibiting cAMP phosphodiesterase type 3 activity in the myocardium and vascular smooth muscle.
CAS:
100286-97-3
Formula:
C15H15N3O4
Molecular Weight:
301.302
Purity:
0.98
SMILES:
CC(O)C(O)=O.Cc1[nH]c(=O)c(cc1-c1ccncc1)C#N

References

1. D?nnes S, Voussen B, Aue A, Groneberg K, Nikolaev V, Groneberg D, Friebe A. Phosphodiesterase 3A expression and activity in the murine vasculature is influenced by NO-sensitive guanylyl cyclase. Pflugers Arch. 2018 Jan 2. doi: 10.1007/s00424-017-2106-8. [Epub ahead of print] PubMed PMID: 29294149. 2. Mehanna OM, El Askary A, Al-Shehri S, El-Esawy B. Effect of phosphodiesterase inhibitors on renal functions and oxidant/antioxidant parameters in streptozocin-induced diabetic rats. Arch Physiol Biochem. 2017 Dec 22:1-6. doi: 10.1080/13813455.2017.1419267. [Epub ahead of print] PubMed PMID: 29271249. 3. Parker WF, Garrity ER Jr, Fedson S, Churpek MM. Trends in the Use of Inotropes to List Adult Heart Transplant Candidates at Status 1A. Circ Heart Fail. 2017 Dec;10(12). pii: e004483. doi: 10.1161/CIRCHEARTFAILURE.117.004483. PubMed PMID: 29246896; PubMed Central PMCID: PMC5739062. 4. Nwaejike N, Son AY, Patel CB, Schroder JN, Milano CA, Daneshmand MA. The Axillary Intra-Aortic Balloon Pump as a Bridge to Recovery Allows Early Ambulation in Long-Term Use: Case Series and Literature Review. Innovations (Phila). 2017 Nov/Dec;12(6):472-478. doi: 10.1097/IMI.0000000000000432. PubMed PMID: 29232299.